AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
S vs RYTM Fundamental Comparison
| Metric | S | RYTM |
|---|---|---|
| Revenue | $1.0B | $189.8M |
| Net Income | $-450.7M | $-196.5M |
| Net Margin | -45.0% | -103.6% |
| ROE | -31.4% | -141.3% |
| ROA | -18.5% | -40.9% |
| Current Ratio | 1.39x | 4.41x |
| Debt/Equity | 0.00x | 0.73x |
| EPS | $-1.37 | $-3.11 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
S vs RYTM: Frequently Asked Questions
Is S or RYTM a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. S is rated SELL (78% confidence) while RYTM is rated SELL (78% confidence). This is not investment advice.
How does S compare to RYTM fundamentally?
SentinelOne, Inc. has ROE of -31.4% vs RHYTHM PHARMACEUTICALS, INC.'s -141.3%. Net margins are -45.0% vs -103.6% respectively.
Which stock pays higher dividends, S or RYTM?
S has a dividend yield of N/A or no dividend while RYTM has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in S or RYTM for long term?
For long-term investing, consider that S has SELL rating with 78% confidence, while RYTM has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about S vs RYTM?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For S vs RYTM, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.